Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Seth Seifman

Critical Insights From Science Applications Intl Analyst Ratings: What You Need To Know

Ratings for Science Applications Intl (NASDAQ:SAIC) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Analysts, Unfazed By 737 Max 9 Grounding, Say Spirit And Boeing Stock Are Buys

Analysts still rate Boeing stock, Spirit AeroSystems a buy after the FAA grounded all 737 Max 9 aircraft.

Investors Business Daily

The Israel-Hamas War: Impact On And Outlook For Defense Stocks

A look at the impact on U.S. defense stocks from the wars launched by Russia in Ukraine and Hamas against Israel.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

China’s Plane Shortage Is Good News for Boeing

After years of anemic sales, the US manufacturer is again bullish on deliveries to Chinese carriers.

Businessweek

JPMorgan Upgrades Aerojet Rocketdyne, Raises Price Target By 22%

Aerojet Rocketdyne Holdings Inc (NYSE:AJRD) has been upgraded to Overweight from Neutral by JPMorgan analyst Seth Seifman. The analyst also raised the price target to $49 from $40 (15% upside). Seifman mentions that the stock's current valuation is attractive, reflecting Aerojet's visible growth, net cash position, and the potential (eventually) to be acquired. According to…

Benzinga

Boeing’s tenuous recovery in china shaken by 737 jet crash

Boeing Co. faces a new crisis after a 737 jet fell out of the sky in China, renewing concerns about its best-selling family of planes and extending one of the most turbulent periods in the aviation titan’s century-long history.

Tribune News Service

JPMorgan Bumps Up Allegheny Price Target Post Q4 Results

JPMorgan analyst Seth Seifman raised the price target on Allegheny Technologies Inc (NYSE:ATI) to $26 (an upside of 15.7%) from $23 and reiterated an Overweight rating on the shares post the Q4 results. Seifman mentions Allegheny's operational results surprised to the upside, with HPMC margins exceeding pre-COVID levels. Related: Allegheny Stock Surges As Q4 Results Top…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.